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Thirty-Day Analysis of Dyspnea and Edema in Heart Failure Subjects 
Description of the Problem 
Heart failure (HF) is a growing epidemic in the United States. Currently, there are 
about 5 million diagnosed cases of heart failure in the United States; there continues to be 
approximately 400,000 new cases diagnosed each year (American Heart Association, 
2004; Reigel & Carolson, 2002). HF primarily affects the elderly, specifically 10 out of 
every 1000 individuals over the age of 65 (Haldeman, Croft, Giles & Rashidee, 1999). 
Given this, as the population of America ages, there will undoubtedly be an increase in 
the number of patients diagnosed with HF. HF is the most common reason for 
hospitalization in the US. Exacerbations are associated with a number of symptoms. 
There is increasing research focused on the causes and effects of delay-time when 
experiencing cardiac symptoms. However, there is little research that examines the 
relationship between daily fluctuations in the symptoms of heart failure and treatment-
seeking delays. 
Pathophysiology of Heart Failure 
Heart failure is the inability of the heart to satisfy the metabolic demands of the 
body. There are two broad types of heart failure: acute and chronic. Acute heart failure 
has a rapid onset of ventricular muscle failure, usually caused by a primary acute event 
such as a myocardial infarction. In acute heart failure, there is an abrupt decrease in the 
contractile ability of the heart to eject blood, which causes an abrupt decrease in cardiac 
output.  
The second type of heart failure is chronic heart failure. Chronic heart failure 






hypertension, valvular disease, cardiomyopathies and arrhythmias. Myocardial systolic 
dysfunction most often results from ischemic heart disease. When the cardiac cells 
become ischemic, there is a loss of the vital elements of the cardiac “pump” and the 
remaining cells are overworked. This stimulates an increase in myocyte size, a decrease 
in capillary density, an increase in intercapillary distance, cardiac dilatation and a 
deposition of fibrous tissue (Weber, 1992). As the heart begins to dilate, the cardiac cells 
stretch and increase the force of contraction and subsequent stroke volume. This is known 
as Starling’s Law.  The increased stretching of the cardiac cells stimulates further 
hypertrophy. Furthermore, myocardial hypertrophy increases wall tension and increases 
myocardial oxygen consumption, which reduces oxygen availability for vital organs. 
Decreases in cardiac output stimulate the sympathetic nervous system, which will 
increase heart rate and induce vasoconstriction as a compensation mechanism to maintain 
normal blood pressure and perfusion of the vital organs. The decrease in contractility 
causes the ventricles to be unable to empty efficiently. In turn, blood is sequestered in the 
lungs or the systemic veins where an increase in hydrostatic pressure moves fluid into the 
interstitial space, alveoli or tissues causing pulmonary edema and an acute shortness of 
breath, generalized edema or organmegaly (Gordan & Child, 2000). 
As cardiac output falls and blood flow to the kidneys is decreased, there is an 
increase in secreted renin as a response. Renin catalyzes the conversion of 
angiotensinogen to Angiotensin I, which in the presence of angiotensin-converting 
enzyme (ACE), is converted to Angiotensin II, a powerful vasoconstrictor. The formation 
of Angiotensin II, primarily in the pulmonary vessels, produces an increase in blood 






adrenal cortex. Aldosterone increases the retention of sodium (and thus fluid) and results 
in increasing blood volume or preload, which adds an additional burden to the heart 
(Gorden & Child, 2000). 
Hormonal alterations are common in HF. Catecholamines, epinephrine and 
norepinephrine, are released from the adrenal medulla and the sympathetic nervous 
system. The release of epinephrine leads to skeletal muscle vasodilatation, whereas 
norepinephrine stimulates peripheral vasoconstriction, an increased mean arterial 
pressure and an increase in afterload. Antidiuretic hormone (ADH) is a hormone released 
from the posterior pituitary gland when stimulated by an increase in plasma osmolality, 
stress, or decreased atrial stretch receptor firing. ADH causes vasoconstriction and 
retention of water by the kidneys. Atrial natriuretic peptide (ANP) is synthesized and 
stored in the cardiac muscle and released when the cardiac chambers are stretched by 
increased blood volume or venous return, often due to fluid overload. ANP produces 
diuresis and natriuresis to reduce excessive blood volume. However, as HF develops over 
time this effect is overwhelmed by the activity of the renin-angiotensin-aldosterone 
system. The result is volume overload, increased afterload and further reductions in 
cardiac output and blood pressure.   
These hemodynamic changes activate baroreceptors in the carotid sinuses and the 
aorta to maintain cardiac output. This stimulation of baroreceptors results in increased 
sympathetic outflow stimulation and a further increase in cardiac contractility and 
vasoconstriction of the peripheral vasculature thus increased blood pressure and heart 
rate. Unfortunately, this response also increases the pressure that the heart has to work 






which makes it more difficult to get the blood to those organs (Gordon & Child, 2000). 
This cyclical decrease in cardiac output will continue until the individual decompensates 
and multiple organ systems malfunction. Death is the eventual outcome without effective 
intervention. 
Signs and Symptoms of Heart Failure 
Given the extensive pathophysiology of heart failure, the signs and symptoms one 
can expect to see in a patient with heart failure include pulmonary congestion and edema, 
systemic venous congestion and peripheral edema, organomegaly, ascites, anorexia, 
confusion, pallor, orthopnoea, dyspnea (at rest and on exertion), tachycardia, tachypnea, 
extra heart sounds, abnormal breath sounds, jugular venous distention and weight gain 
(Gordon & Child, 2000).  
New York Heart Association Classifications 
Signs and symptoms develop over time and may vary from individual to 
individual or from day to day. The affect of these symptoms on daily life is used to 
classify patients. The New York Heart Association established a classification scale for 
patients with cardiac disease based on functional status. Classifications are as follows: 
Class I.  Patients with cardiac disease but without resulting limitation of physical activity. 
Class II. Patients with cardiac disease resulting in slight limitation of physical activity 
Class III. Patients with cardiac disease resulting in marked limitation of physical activity. 
Class IV. Patients with cardiac disease resulting in inability to carry on any physical 






This classification system is primarily utilized to classify severity of functional 
restrictions, to establish treatment regiments for patients with heart failure and has been 
widely used over the past 50 years (Hurst, Morri & Alexander, 1999). 
Review of Literature 
Delay of Treatment 
Excessive delay time has been found to contribute to an increase in morbidity and 
mortality in cardiac patients (Cooper, Simmons, Casstanar, Prasad, Franklin & Freelinz, 
1986; Johnson & King, 1995). If there is a time window between cardiac symptom 
exacerbation and hospital admissions, during which health care providers could intervene 
earlier, this might prevent hospitalization and other serious physiological consequences 
for the patient (Schiff et al., 2003). Although HF is a serious and potentially deadly 
disease, there is very little consistency in the amount of time it takes for a patient 
experiencing cardiac symptoms to seek treatment. 
In a sample of heart failure patients (n= 753) at a Veterans Administration facility, 
Evangelista et al. (2000) found that the mean delay time between a patient’s first 
awareness of their cardiac symptom and their arrival at the hospital was 2.93 + 0.68 days. 
The detection of dyspnea and edema nearly doubled the time to treatment when 
compared with those who did not have these symptoms. A higher New York Heart 
Association class and care by a primary care physician also prolonged delay time. The 
factors associated with a decrease in delay time were presence of chest pain and a 
previous history of HF admissions. Therefore, there are many factors that affect when a 






Schiff, Fung, Sperof and McNutt (2003) studied a sample of patients (n = 87) 
admitted to a public general hospital with a diagnosis of heart failure. These investigators 
found that the worsening of cardiac symptoms was an observed mean of 12.4 + 1.4 days 
before admissions for edema, 11.3 + 1.6 days for weight gain and 8.4 + 0.9 days for 
dyspnea. They identified a period of days to weeks between the onset of worsening 
cardiac symptoms and hospital admissions for heart failure decompensation. This study 
demonstrated that patients can detect changes in their HF symptoms and that those 
changes may be signs of an impending HF exacerbation. However, these subjects did not 
act on their symptom changes for more than a week. 
 In a study by Friedman (1997) of elderly HF patients (n = 181) in an acute care 
facility, 91% of the subjects reported experiencing dyspnea for an average of 3 days 
before seeking treatment. He compared this with the 4 to 12-day duration of cardiac 
symptoms in a younger cohort of patients and concluded that more intensive patient 
education addressing prompt health care seeking was necessary.  
Reasons for delay 
Delays in seeking treatment are very costly and can result in death of a patient. 
When examining why patients with heart failure have difficulties in self-care, specifically 
the recognition of symptoms, Carlson, Riegel & Moser (2001) found most patients (n = 
139) had a very difficult time recognizing the symptoms of heart failure. They also 
reported that patients with experience addressing heart failure symptoms recognized them 
easier than those who are newly diagnosed. These investigators found several factors 
limiting their subject’s ability to recognize their symptoms. These include comorbidities, 






monitor the symptoms of one illness, but trying to identify and differentiate between 
several chronic conditions is much more challenging. These investigators also identified 
that confidence in one’s ability to effectively treat their cardiac symptoms was low in this 
sample. The investigators speculated that might be why patients wait so long with 
worsening symptoms before seeking treatment, often in an emergency department (ED). 
Another potential reason for delays in seeking treatment for one’s heart failure is 
self-care. Self-care management includes general health maintance activities that are 
imperative to maintaining a high quality of life in patients with heart failure. Carlson et 
al. (2001) found that while patients with heart failure were following general health 
maintance recommendations, such as smoking cessation and alcohol avoidance, less than 
half of these patients exercised regularly. These researchers speculated that this may be 
due to a lack of education about the safety and necessity of regular exercise among 
patients with heart failure. Additionally, Rockwell and Riegel (2001) found that patients 
with higher education and those who are symptomatic are more likely to engage in self-
care more often than those patients who are uneducated and asymptomatic. The finding 
that patients with higher education perform self-care more often than those patients with 
less education has been supported in other research (Rockwell & Riegel, 2001). 
However, the finding that patients experiencing more cardiac symptoms were more 
knowledgeable about symptoms requiring self-care differs from previous investigations. 
Rockwell and Riegel (2001) concluded that patients with more disease-related symptom 
experience have engaged in self-care more often than those who do not have this history 







In an additional investigation, Carlson, Riegel and Moser (2001), found that 
misconceptions and lack of knowledge are barriers to self-care. Also, patients with heart 
failure often do not seek any treatment until re-hospitalization is imminent. They found 
that most of these patients were unable to evaluate the meaning and importance of their 
cardiac symptoms and/or did not believe that their self-care could help relieve their 
symptoms. Carlson et al. (2001) also identified personal struggles, negative emotions, co-
morbid conditions, physician support and control as potential barriers to self-care in 
patients with heart failure. While all of these studies explored possible reasons why there 
is a large variation in the amount of time it takes for a symptomatic patient with heart 
failure to seek treatment, none looked at the daily variation of symptoms. 
Dyspnea 
Dyspnea is the most common symptom of heart failure and is the primary reason 
individuals seek treatment in an emergency department (Parshall, Welsh, Brockopp, 
Heiser, Schooled & Cassidy, 2001). Dyspnea and chest pain are the most common 
symptoms reported upon admission to the ED for HF patients (Evangelista, et al, 2000) 
According to Parshall et al. (2001), there variations in intensity of dyspnea and distress 
experienced during a heart failure exacerbation. Dyspnea is one of the hallmark 
symptoms of heart failure and very often contributes to a patient seeking treatment for 
their heart failure exacerbation and there are documented correlations in the relationship 
between dyspnea variation and treatment-seeking (Parshall et al., 2001). 
Parshall et al. (2001) found that there is a general increase in distress related to 
dyspnea over the week before deciding to seek treatment in the ED (n = 52). Specifically, 






having been severe for one day or less before presenting to the ED, that slightly more 
than one third (35%) indicated their dyspnea had been that severe for more than 6 days, 
and that only a few (11%) fell in between. Parshall et al. (2001), identified two distinct 
groups of patients who experienced dyspnea secondary to heart failure: those who 
experienced an increase in dyspnea intensity and distress over a short period of time (3 
days or less) and those who experienced no change in intensity and distress up to a week 
before seeking treatment. They concluded that those with less tolerance for symptoms 
had a more dynamic conceptualization of their dyspnea and those with a greater tolerance 
for dyspnea had a more static conceptualization of it and thus a longer duration prior to 
seeking care. 
Weight Gain and Edema 
The activation of the renin-angiotensin-aldosterone system leads to the retention 
of fluid and a systemic increase in blood volume with subsequent pulmonary and 
systemic congestion. In patients with heart failure, significant weight gain is one sign that 
may predict a heart failure exacerbation. Accordingly, when patients are diagnosed with 
heart failure, they are educated to weigh themselves daily and to call their practitioner’s 
office with any significant changes, i.e., any change > 2-3 lbs overnight or > 3-5 lbs in 
one week (Heart Failure Society of America, 2003). 
A review of the current literature yielded several articles addressing weight gain 
in patients with HF, however most of these are descriptive articles examining the 
relationships between fluid dynamics, thiazolidinediones and heart failure (Giles, 2003; 
Hollenberg, 2003; Tang, Francis, Hoogwerf & Young, 2003). Thiazolidinediones are 






These studies do indicate that when a patient is diagnosed with HF and diabetes mellitus, 
there is a potential for weight gain as a result of fluid retention or fat accumulation (Giles, 
2003). Hollenberg (2003) suggested that in new-onset heart failure, edema is uncommon, 
and it is even less common in patients taking thiazolidinediones to control their diabetes 
mellitus. A study by Tang et al. (2003) concluded that a direct association between the 
risk of fluid retention and the baseline degree of severity of HF has yet to be established 
and that patients with HF who are being treated with thiazolidinediones experienced a 
pattern of edema opposite to a pattern during direct myocardial depression (i.e., there is 
more peripheral edema than pulmonary edema). A patient may experience dyspnea and 
weight gain simultaneously. As there is an increase in fluid retention, pulmonary 
congestion may result and it becomes harder for a person to breathe. Thus, in this study 
we looked at weight gain and self-reported edema as they fluctuated from day to day and 
determine the association with dyspnea in a group of HF patients.  
Conclusion 
The most commonly recognized symptoms of a HF exacerbation are dyspnea and 
edema. Although there are significant changes in the signs and symptoms of patients 
experiencing a HF exacerbation, research shows that there is a large variation in when 
these patients seek medical treatment. This may occur because some patients may think 
that a slight increase in dyspnea, edema or weight is a normal fluctuation when in reality 
it is an early sign of a HF exacerbation. These patients may tend to rely on past 
experiences to guide their self-care, and may feel that their symptoms will improve in 1-2 
days without any medical intervention.  Most HF patients are taught to notify their health 






but there are no studies that investigate normal fluctuations in signs and symptoms that 
may influence the decision to seek treatment.  
Study Purpose 
The purpose of this study was to characterize daily fluctuations in self-reported 
dyspnea, edema, and body weight in subjects with the New York Heart Association class 
I through IV HF for one month. Our specific aims were: 
1. To describe daily fluctuations in self-reported dyspnea, edema and body weight; 
2. To examine relationships between self-reported dyspnea, edema and body weight in 
this cohort; and 
3. To evaluate the relationship between symptom stability and emergency department 
visits and hospitalization. 
Methods 
Design 
This was a descriptive correlational study. Data were collected daily for 30 days 
from a cohort of heart failure subjects (n = 48). Association between self-reported 
dyspnea, edema and body weight were determined. 
Sample & Setting 
This investigation was a sub-study of a larger investigation titled “Appetite, 
nutrition, and inflammation in patients with heart failure”.  For this investigation, we 
studied a sample of 48 subjects who met the following inclusion criteria: (a) diagnosis of 
HF with a left ventricular ejection fraction of = 40%, (b) stable on medication regimen 
for at least 3 months, (c) no history of myocardial infarction in previous 3 months, (d) 






The exclusion criteria included (a) valvular heart disease, (b) history of cerebral vascular 
accident, (c) co-existing terminal illness or other illness known to be associated with 
decreased appetite and weigh loss or (d) have been referred for heart transplantation. 
Subjects were recruited from the three Midwestern HF clinics, two in central Ohio and 
one in central Kentucky. For this sub-study, a convenience sample of 48 subjects with 
NYHA classification I-IV HF was selected.  
Procedure 
Institutional review board approval was obtained from The Ohio State University 
Biomedical Institutional Review Board. Subjects were referred to the investigators by 
cardiologists and nurse practitioners. Referred subjects were contacted by telephone, 
received a clear explanation of the study and were invited to participate in the study. The 
researchers explained the informed consent to the subjects via the telephone. Following 
verbal consent, a research assistant obtained signed, informed consent at the subjects’ 
home. During this visit, baseline data collection was completed with questionnaires that 
included: (a) demographic data and (b) daily symptom rating scale. Daily, for the next 30 
days, the subjects recorded severity of heart failure symptoms. These included evaluation 
of anxiety, appetite, fatigue, depression, sleeplessness, dyspnea, edema, and weight gain, 
using a 10-point analog scale with zero indicating the “worst it has ever been” and ten 
indicating the “best it has ever been”. This reported analysis only included dyspnea, 
edema and body weight. Experts in the field of heart failure were used to establish face 
validity of the instrument.  The subject evaluated and recorded symptoms and body 
weight was measured and recorded using a calibrated scale. All measures were made at 








Descriptive statistics were used to characterize the sample (see Table 1). This 
study had 48 participants with a mean age of 48 + 15 years. More than half of the 
participants were male (54.2%) and most were married (54.2%) More than half of the 
subjects were retired (52.1%), one-third were on sick leave or disability (41.7%) and the 
remaining subjects were employed full or part time outside the home (6.3%). A majority 
(54.2%) of the sample was classified as NYHA class III; overall, subjects had a mean 
ejection fraction of 30.3 + 14.1%. The mean yearly income was $30,827 for the 
participants and almost 90% of this sample had access to medical insurance. This sample 
had an above average educational level of 12.7 + 2.52 years.  
Daily mean dyspnea score 
Subjects were asked to rate their daily shortness of breath at the same time every 
day using a 0 to 10 scale with zero being the “worst I have ever experienced” to ten 
indicating, “the best I have ever experienced”.  Ratings ranged from 0 to 10.  The average 
daily rating of dyspnea for the sample ranged from 5.2-6.9, indicating moderate daily 
dyspnea. There were significant daily fluctuations. For example, the average daily rating 
on day 3 was 5.2 and on day 6, the average rating was 5.9. There were similar 
fluctuations throughout the 30-day period. (see Figure 1)  
Daily mean self reported edema 
Subjects were asked to rate their daily perceived edema at the same time every 
day using a 0 to 10 scale with zero being the “worst I have ever experienced” to ten 






daily rating of self-reported edema ranged from 3.0 to 5.2, indicating moderate to severe 
daily self-reported edema. There were fewer daily fluctuations in self-reported edema and 
the ratings remained stable for this time period (see Figure 2). 
Mean daily body weight 
Subjects were asked to weigh themselves on the same calibrated scale everyday at 
the same time for 30-day period. Subjects recorded their daily weight in pounds. Average 
daily weight ranged from 176.9 lbs to 186.6 lbs. Average daily weight for the 30-day 
period was 180.2 + 44.9 pounds (see Figure 3).  
Association between self reported dyspnea and edema  
 
The association between self-reported dyspnea and edema was evaluated using a 
Spearman correlation coefficient based on the ordinal level of the data. This association 
was significant at the p < 0.01 significance level every day during the 30-day time period. 
This was a positive relationship. As a participant reported more edema, there was a 
corresponding increase in rated dyspnea (see Table 2).  
Association between body weight and dyspnea 
The association between self-reported dyspnea and body weight was evaluated 
using a Spearman correlation coefficient based on the ordinal level of the dyspnea data. 
Few of the associations between body weight and self-reported dyspnea were significant 
at the p < 0.05 significance level. This relationship was a negative relationship, which 
indicated as body weight increased, the dyspnea rating decreased (meaning greater 
dyspnea) and the actual dyspnea experienced increased (see Table 3).  
Association between body weight and self-reported edema 
 






using a Spearman correlation coefficient based on the ordinal level of the edema rating. 
Few of the associations between self-reported edema and body weight were significant at 
the p < 0.05 significance level. These were negative relationships. As body weight 
increased, the self-reported edema rating decreased (meaning greater edema), and the 
actual edema experienced increased (see Table 4).  
Symptom stability, emergency department visits and hospitalizations 
 
The investigators divided the sample into stable and unstable groups based upon 
their daily dyspnea rating. The investigators defined a stable participant as one who had 
daily dyspnea rating within + 1 from day 1 on the visual analog scale over the 30-day 
time period. An unstable participant was one whose daily dyspnea rating varied greater 
than a + 1 rating, from day one on the visual analog scale over the 30-day time period. 
This value was chosen based on the Parshall et al. (2001) investigation. Twenty-six 
(66.7%) participants were classified as stable and 16 (33.3%) were classified as unstable.  
Mean ED visits and hospitalizations were compared for the two groups using an 
independent t-test. There was a significant difference in the total number of ED visits 
between the groups (p < 0.05). The unstable symptom group had 0.69 + 0.8 visits, 
whereas; the stable symptom group had only 0.15 + 0.4 visits (see Table 5). There was 
also a significant difference between the total number of hospitalizations between the 
stable and the unstable group (p < 0.05). During the 30-day time period, the unstable 
symptom group was hospitalized a mean number of 1.46 + 1.9 times, whereas, the stable 
symptom group was hospitalized an average of 0.31 + 0.6 times (p < 0.05). Thus, the 
unstable symptom group was more likely to visit the ED and be hospitalized compared 







During the 30-day study period, subjects with heart failure reported moderate 
levels of self-reported dyspnea and edema.  There were fewer daily fluctuations in self-
reported edema than in self-reported dyspnea. There were fairly large fluctuations in 
weight over the 30-day period. We also found that the daily relationship between self-
reported dyspnea and edema was a positive, significant relationship (p < 0.01). This 
signified that as the participants reported more edema, there was a corresponding increase 
in their dyspnea. The relationship between self-reported dyspnea and body weight was 
significant for 3 days (p < 0.05), which indicated that as body weight increased, self-
reported edema increased. There were a few significant positive correlations between 
self-reported edema and body weight. As body weight increased so did self-reported 
edema. The sample was divided into stable and unstable groups based upon their daily 
dyspnea rating.  Two thirds of subjects experienced stable dyspnea. There was a 
significant difference between the total number of ED visits and hospitalizations between 
the stable and the unstable group. Those subjects with more symptom variability were 
more likely to visit the ED and be hospitalized than those subjects with less symptom 
variability during the 30-day period.  
This is the first study to describe the daily variations in self-reported dyspnea, 
edema and body weight in a group of heart failure subjects and to evaluate the 
associations between these variables. Even though our sample was classified as NYHA I-
IV, self-reported dyspnea was rated as moderate on average for the group. Self-reported 
edema was also rated as moderate to severe on average for the period. This reflects the 






Class III. This classification indicates marked limitation in physical activity due to HF 
symptoms and moderate to severe symptom ratings would be expected. However, slightly 
more than one third (35.5%) was class I or II, which would indicate little interference 
with functional ability. Overall, dyspnea and edema were self-rated as moderate to severe 
on a daily basis for the group as a whole. This may reflect the severity of self-reported 
symptoms by the majority of the sample. 
Several prior investigations have identified that HF patients have worsening 
symptoms for days prior to an exacerbation, which led to an ED visit or hospitalization. 
Schiff et al. (2003) found that worsening dyspnea was detected for 8.4 + 0.9 days prior to 
a heart failure exacerbation. Evangelista et al. (2000) found that the mean delay time 
between a patient’s first awareness of cardiac symptoms (dyspnea, edema, fatigue and 
angina) and their arrival at the hospital was 2.93 + 0.58 days.  Friedman (1997) found 
that subjects reported worsening dyspnea for an average of 3 days before seeking 
treatment. In our study, unstable self-reported dyspnea was more likely to result in an ED 
visit or a hospitalization during the 30-day period. This indicates that patients with 
unstable HF symptoms like dyspnea are more likely to interpret these symptoms changes 
as worsening of HF and seek treatment in the ED; these subjects were also more likely to 
be experiencing an exacerbation that required hospitalization. 
These data described the daily weight fluctuations of these subjects. We found 
that there were large fluctuations during the 30-day period. These changes may be due to 
alterations in activity, diet and medication use, which may also be related to individual 






investigation and determination of factors associated with daily alterations in body 
weight in this population of patients. 
There was a strong association between self-reported dyspnea and edema. This 
likely is the result of increased pulmonary congestion. There was also an association 
between self-reported dyspnea and body weight that indicated the increase in blood 
volume produced a detectable increase in dyspnea, most likely due to greater pulmonary 
congestion. These findings also suggest that patients can detect daily changes in their 
symptoms, which may help the patients modify their health behaviors and self-care, as 
well as provide a cue for contact their primary health care provider to report these 
changes in symptoms. These data also indicated some significant association between 
self-reported edema and body weight. This may indicate that subjects detected the 
redistribution of fluid, rather than a change in fluid volume status with changes in daily 
symptom detection.  
We found that patients with stable dyspnea were less likely to visit the ED or be 
hospitalized than those with unstable dyspnea. This finding may be useful to health care 
practitioners who work with HF patients. Practitioners may have HF patients keep a 
written or electronic log of their daily symptom severity to evaluate individual 
differences in symptoms. Those with unstable symptoms may require adjustment to their 
therapeutic regimen or additional contact with a health care provider. Follow-up care and 
teaching may also be based on this evaluation to ensure continued appropriate 
management of HF symptoms. Practitioners may also want to regularly contact unstable 








There were several limitations to this investigation. We had a small sample size (n 
= 48), which influenced the power of the statistical analyses. The visual analog scale used 
to evaluate daily symptom severity was inverted from more commonly used visual analog 
scales (zero being the worst I have ever experienced to ten indicating the best I have ever 
experienced). Also, it may have been difficult for these subjects to conceptualize 
symptom severity with the numerical ratings on the visual analog scale. These data were 
subjective, self-reported ratings and lacked any objective, standardized criteria for the 
subjects to use to gauge their daily symptom severity.  However, symptoms are 
subjective and self-report is the best way of evaluating the subject’s perception of those 
symptoms.  
Conclusion 
Modern health care requires patients to be active participants in maintaining a 
healthy, fruitful life. The patient must understand their bodies and their diseases and 
become the first person aware of deviations from normal. This study sought to illustrate 
that patients can recognize variability in their heart failure symptoms.  
For the 30-day study period, subjects with heart failure reported moderate levels 
of self reported dyspnea and edema. The mean dyspnea rating was significantly 
associated with changes in body weight indicating that fluid retention increased the 
sensation of breathlessness. Self reported dyspnea was also associated with self-reported 
edema. Heart failure patients are able to monitor daily symptoms, detect small changes 
and may be able to modify self-care activities and therapeutic regimen based on these 






to have ED visits and hospitalizations. This information could be used to help 
practitioners to evaluate daily symptom ratings and to tailor patient monitoring and 
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SD = standard deviation 
 




 Frequency (%) Mean + SD 
Age  48 + 14.7 years 
Gender 
  Male  
  Female 
 
26 (54.2%) 









      11         (27.1%) 
 
 
Education Level  12.7 + 2.52 years 
Ejection Fraction  30.3 + 14.1 % 


























Spearman correlation coefficients 

























 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Week 1 .576** .611** .563** .599** .671** .633** .598** 
Week 2 .544** .493** .542** .550** .612** .617** .475** 
Week 3 .666** .550** .462** .483** .568** .525** .618** 













Spearman correlation coefficients 


























 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Week 1 -.194 -.266 -.314* -.287 -.180 -.349* -.243 
Week 2 -.213 -.225 -.108 -.249 -.205 -.164 -.190 
Week 3 -.354* -.269 -.232 -.227 -.223 -.161 -.156 















Spearman correlation coefficients 
























 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Week 1 -.172 -.249 -.225 -.221 -.235 -.298* -.298* 
Week 2 -.212 -.236 -.301 -.262 -.302* -.195 -.209 
Week 3 -.298 -.257 -.200  -.254 -.284 -.183 






Table 5. A comparison of hospitalizations and emergency department visits for 









 N Mean SD t df p value 


























































































































































































































Figure 3. Average daily weight for 30 days (n = 48) 
